LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today

Kadimastem (TASE: KDST)

Human stem cell-based medical solutions for the treatment of diabetes and neurodegenerative diseases, such as ALS and Multiple Sclerosis.

Get a Demo and See the Full Profile

Get a demo today to see profiles of Kadimastem (TASE: KDST) plus 6117 other startups.

Learn More About Kadimastem (TASE: KDST)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More